Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF COMPLEX OF CYSTEINE PROTEASE INHIBITOR SN AND CATHEPSIN H AS ESOPHAGEAL CANCER DIAGNOSTIC MARKER
Document Type and Number:
WIPO Patent Application WO/2022/083580
Kind Code:
A1
Abstract:
The present application relates to the use of a complex of cysteine protease inhibitor SN and Cathepsin H as an esophageal cancer diagnostic marker, and a kit for esophageal cancer diagnosis, auxiliary diagnosis or prognosis analysis.

More Like This:
WO/2006/078746METHOD, COMPOSITIONS AND CLASSIFICATION FOR TUMOR DIAGNOSTICS AND TREATMENT
JP4723472Gene expression marker for breast cancer prognosis diagnosis
WO/2020/061632ANALYTE QUANTITATION
Inventors:
WANG LIJUN (CN)
SUN YULONG (CN)
YANG YAYUN (CN)
WANG TAO (CN)
Application Number:
PCT/CN2021/124682
Publication Date:
April 28, 2022
Filing Date:
October 19, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI LIANGRUN BIOMEDICINE TECH CO LTD (CN)
International Classes:
G01N33/574; G01N33/543; G01N33/577
Foreign References:
CN112379094A2021-02-19
CN112379093A2021-02-19
CN103901205A2014-07-02
CN103898205A2014-07-02
CN107807243A2018-03-16
US20160138113A12016-05-19
US20090123925A12009-05-14
Attorney, Agent or Firm:
ADVANCE CHINA IP LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: TEST METHOD FOR REFRIGERATOR, AND REFRIGERATOR

Next Patent: REFRIGERATOR AND CONTROL METHOD THEREFOR